Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor.
Yan LiuYehui ZhouKuo-Hsiang HuangXujie FangYing LiFeifei WangLi AnQingfei ChenYunchao ZhangAihua ShiShuang YuJingzhong ZhangPublished in: Cell proliferation (2020)
This study suggested that treatment with EGFR-CAR NK cells could be a promising strategy for TNBC patients.